Omigapil
- Generic Name
- Omigapil
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H17NO
- CAS Number
- 181296-84-4
- Unique Ingredient Identifier
- 5V14HD0N4Q
- Background
Omigapil has been used in trials studying the treatment of Congenital Muscular Dystrophy.
- Associated Conditions
- -
- Associated Therapies
- -
Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT01805024
- Locations
- 🇺🇸
NINDS, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath